REQUEST A DEMO
Total
USD $0.00
Search more companies

Velexfarm D.O.O. Beograd (Serbia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Velexfarm D.O.O. Beograd Profile Updated: June 12, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Velexfarm D.O.O. Beograd is a pharmaceutical company. They distribute pharmaceutical and para-pharmaceutical products, including prescription and over-the-counter medications, as well as dietary supplements. They focus on logistics and have developed a new business model to ensure the equal distribution of quality pharmaceutical products throughout Serbia.

Headquarters
Prote Mateje 70
Beograd-Vracar; Beograd-Vracar;

Contact Details: Purchase the Velexfarm D.O.O. Beograd report to view the information.

Website: http://www.velexfarm.rs

Basic Information
Total Employees:
Purchase the Velexfarm D.O.O. Beograd report to view the information.
Outstanding Shares:
Purchase the Velexfarm D.O.O. Beograd report to view the information.
Registered Capital:
Purchase the Velexfarm D.O.O. Beograd report to view the information.
Financial Auditors:
Purchase the Velexfarm D.O.O. Beograd report to view the information.
Incorporation Date:
September 20, 2010
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Representative
Purchase this report to view the information.
Representative
Purchase this report to view the information.
Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Velexfarm D.O.O. Beograd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RSD. Absolute financial data is included in the purchased report.
Net sales revenue
15.87%
Total operating revenue
15.87%
Operating profit (EBIT)
112.04%
EBITDA
92.85%
Net Profit (Loss) for the Period
114.62%
Total assets
17.36%
Total equity
99.89%
Operating Profit Margin (ROS)
1.65%
Net Profit Margin
1.21%
Return on Equity (ROE)
3.44%
Debt to Equity Ratio
-6.95%
Quick Ratio
0.04%
Cash Ratio
-0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?